| Mycosis Fungoides studied in …STUDIED_INderived126 of 126show fewer |
|---|
| → studied in | NCT05944562Phase 1 · active not recruiting Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07003100recruiting A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03380026Phase 2 · completed Mechlorethamine Induced Contact Dermatitis Avoidance Study · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04930653Phase 2 · recruiting Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Folliculotropic Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04904146recruiting Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome. · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781449Phase 2 · not yet recruiting Topical JAK-Inhibition of Early-Stage CTCL · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07055477Phase 1 · recruiting A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02702310suspended Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03011814Phase 1/Phase 2 · recruiting Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05357794Phase 2 · recruiting Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07717580Phase 2 · not yet recruiting Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL) · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377827Phase 1 · suspended Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Transformed Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714187Phase 1 · not yet recruiting A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01352520Phase 2 · active not recruiting SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06207812recruiting Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580002Phase 2 · recruiting Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470451Phase 3 · terminated Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04256018Phase 2 · recruiting Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06508463Phase 1 · recruiting Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02520791Phase 1 · active not recruiting Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07658924Phase 2 · not yet recruiting Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05414500Phase 1 · suspended Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602157Phase 1 · active not recruiting Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04960618Phase 2 · active not recruiting Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017820Phase 1 · recruiting A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06113081completed Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598998Phase 1/Phase 2 · active not recruiting Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02943642Phase 2 · withdrawn Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05838599early Phase 1 · recruiting Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05680558Phase 2 · recruiting Photopheresis in Early-stage Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03398161Phase 2 · recruiting Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529405Phase 2 · not yet recruiting A Study of VG712 in Patients With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587844Phase 2 · recruiting Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235281early Phase 1 · suspended Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05872854Phase 2 · completed Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07362225recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03278782Phase 1/Phase 2 · active not recruiting Study of Pembrolizumab (MK-3475) in Combination With Romidepsin · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04686682Phase 1/Phase 2 · recruiting A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00177268recruiting Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06588868recruiting Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07235813NA · completed IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06716658Phase 2 · recruiting JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02848274recruiting ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541017Phase 1/Phase 2 · terminated Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213882early Phase 1 · not yet recruiting A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL) · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04074746Phase 1/Phase 2 · completed Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04234048Phase 1 · recruiting Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07132567recruiting Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03695471Phase 2 · completed Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06149247Phase 2 · completed HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021495recruiting SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879458Phase 2 · terminated Ritlecitinib in CTCL · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07046663not yet recruiting Long-term Assessment of Chlormethine Gel in Mycosis Fungoides · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538988Phase 1/Phase 2 · withdrawn BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03432741Phase 1 · terminated Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00368784completed T Cell Repertoire Analysis of Immune Mediated Skin Diseases · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03288818Phase 2 · withdrawn Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06782854completed Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04774068Phase 1 · completed Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Transformed Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04101331Phase 2 · completed Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Transformed Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02953301Phase 2 · completed Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04676087Phase 1/Phase 2 · terminated Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06436677recruiting A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03789864NA · terminated Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06421571unknown The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05904522NA · unknown Histopathological Changes in Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047060Phase 1/Phase 2 · completed Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05138458Phase 1/Phase 2 · suspended A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05380635Phase 2 · completed PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01579318Phase 2 · terminated Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05855460unknown Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890368Phase 1 · terminated Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05526638NA · unknown Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303480NA · completed Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03281811early Phase 1 · completed Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185220Phase 1 · completed Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02811783Phase 3 · terminated Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04118868Phase 1 · unknown Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma. · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03905135Phase 1 · completed Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883517completed Cell-free Circulating DNA in Primary Cutaneous Lymphomas · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03713320Phase 2 · terminated SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491825unknown Diagnostic Classifier for Cutaneous T-cell Lymphomas · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04955340Phase 1 · completed A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05205902Phase 3 · not yet recruiting TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02323659Phase 4 · terminated Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02301494NA · withdrawn Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02341209Phase 2 · terminated Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04702503Phase 1 · completed Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL) · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01578499Phase 3 · completed A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02580552Phase 1 · completed Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03837457Phase 2 · terminated PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03075553Phase 2 · terminated Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01609816Phase 1 · terminated Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02296164completed Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134341Phase 1 · completed Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445340Phase 1 · terminated Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02652715NA · completed Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02822586Phase 1 · completed TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03373305Phase 1 · withdrawn Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas · condition mapped CURATED_BROADER · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02542124Phase 2 · unknown NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038376Phase 2 · completed Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01590732Phase 1 · completed Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00221039Phase 4 · completed Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03267407unknown Vietnam Cryptococcal Retention in Care Study - Version 2.1 · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00985140terminated Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091559Phase 2 · completed Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001) · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01396070Phase 2 · completed Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00226993Phase 1/Phase 2 · withdrawn Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides. · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00611208Phase 2 · completed A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02881749Phase 2 · unknown Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01556828terminated Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00178841Phase 2 · completed Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00129415Phase 1/Phase 2 · terminated Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00254332completed Effect of Denileukin Diftitox on Immune System in CTCL Patients · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00185965Phase 1/Phase 2 · completed CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00177190completed In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL) · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00168064Phase 2 · completed Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00535470Phase 2 · completed An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00127881Phase 3 · terminated Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00630903Phase 4 · terminated PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides · condition mapped ALIAS · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00050999Phase 4 · completed Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00051012Phase 4 · completed Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00496743NA · terminated Study of Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00157274Phase 2 · unknown Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 126 trials mapped (42 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |